Physician profile
Arie Salzman
NPI 1467490466
$12,938.70
in general payments reported to CMS, 2019-2025
10 companies · $658 in 2025
The $658 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,661 · 2020: $228 · 2021: $517 · 2022: $926 · 2023: $217 · 2024: $731 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Consulting Fee: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.47 |
| Consulting Fee | $108.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Think Surgical, INC. | $9,232.90 | 2019 | |
| Stryker Corporation | $1,128.65 | 2019-2025 | Mako, Triathlon, Pangea |
| Smith+Nephew, INC. | $777.11 | 2021-2025 | Grafix Pl, Stravix, Stravix Pl |
| Radius Health, INC. | $544.61 | 2020-2025 | Tymlos |
| Zimmer Biomet Holdings, INC. | $409.79 | 2019-2022 | |
| Depuy Synthes Sales INC. | $319.34 | 2020-2023 | Na |
| Next Science LLC | $312.66 | 2024-2025 | Blastx, Xperience, Surgx |
| Orthalign INC | $143.94 | 2022 | |
| Medacta USA, INC. | $59.00 | 2023 | Gmk Sphere |
| Innovation Technologies INC | $10.70 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arie Salzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.